Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Clinical
The European Commission has Granted Orphan Medicinal Product Designation in the…
Clinical
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Clinical
Discovery of new step in how brain cells work could lead…
Home
Clinical
Phase IV
Phase IV
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase IV
First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar Gel (Repository Corticotropin Injection) for Severe Keratitis
Firstwordpharma News
-
December 16, 2019
- Advertisement -
MOST POPULAR
AVROBIO Receives Orphan Drug Designation from U.S. FDA for AVR?RD?04 for...
March 9, 2020
Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its...
June 27, 2019
Society for Science & the Public Announces Regeneron as New Title...
December 12, 2019
Asana BioSciences to Present Correlation Between Microbiome Changes and Clinical Efficacy...
February 18, 2019
Load more
HOT NEWS
Others
Eloxx Pharma Replaces CEO, Shifts Board to Refocus on Cystic Fibrosis...
Acquisitions
Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets...
Others
Sanofi Selects Novartis Executive to Replace Retiring CEO
Others
The Neuroscience of Autism: New Clues for How the Condition Begins
